BNET Industries
- Private
- US
Dow Jones Description
Aphton has an aptitude for averting cancer. Founded in 1981 and headquartered in Philadelphia, PA, Aphton Corporation is a biopharmaceutical company with an emphasis on developing immunotherapies used to fight cancer. The company develops immunogenic-based drugs that counterbalance hormones that are found in several gastrointestinal cancers, such as those of the pancreas, liver, and stomach. The drugs can also help to treat diseases such as stomach ulcers and reflux disease. The company is now working on Insegia, a vaccine that would be used to fight pancreatic cancer. The company had no revenue in 2005 and employs about 66 people. In March 2005, the company acquired Igeneon AG.
Co-CEO
William A. HaslerNumber of Employees 66
Contact Information
Ste 2300 1628 John F Kennedy Blvd
Philadelphia, Pennsylvania 19103-2128
(305) 374-7338
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
aphton corp. and asco plc. - All News and Analysis
Aphton Corporation presents Phase III Clinical Trial Results of G17DT as Monotherapy in Patients with Pancreatic Cancer at ASCO
- 2004-06-07
Business Editors/Health/Medical Writers BIOWIRE2K MIAMI--BUSINESS WIRE--June 7, 2004 Aphton Corporation (Nasdaq:APHT) announced today that the positive results of its Phase III trial testing G17DT as a monotherapy for patients with advanced pancreatic cancer who are unable to tolerate or unwilling to take chemotherapy were presented on Sunday,...
Aphton Corporation Presents at ASCO the Results of a Study Determining the Immune Response to GD17 Immunogen as a Predictor for Survival in Colorectal, Gastric and Pancreatic Cancers
- 2004-06-07
Business Editors/Health/Medical Writers BIOWIRE2K MIAMI--BUSINESS WIRE--June 7, 2004 Aphton Corporation (Nasdaq: APHT) announced today results of a study establishing the immune response to G17DT immunogen as a predictor of survival in patients with colorectal, gastric and pancreatic cancers. Paul Broome, MB., Ch.B., FFPM, Aphton's Vice president and...
Aphton Corporation Presents Phase II Clinical Trial Results of G17DT Immunogen in Combination with Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer at ASCO
- 2004-06-07
Business Editors/High-Tech Writers BIOWIRE2K MIAMI--BUSINESS WIRE--June 7, 2004 Aphton Corporation (Nasdaq:APHT) announced today results of its worldwide, multicenter, Phase II study of G17DT Immunogen in combination with irinotecan-based chemotherapy in patients with irinotecan-refractory metastatic colorectal cancer. The results were presented on Saturday June 5th by C. Rocha...
Aphton Corporation Presents Phase II Clinical Trial Results of G17DT Immunogen in Combination with Chemotherapy in Gastric and Gastroesophageal Cancer at ASCO
- 2004-06-07
Business Editors/Health/Medical Writers BIOWIRE2K MIAMI--BUSINESS WIRE--June 7, 2004 Aphton Corporation (Nasdaq:APHT) announced today that the positive results of its multicenter Phase II study of G17DT Immunogen in combination with cisplatin CDDP and 5-Fluorouracil (5-FU) in chemotherapy naive patients with locally recurrent or metastatic gastric and gastroesophageal cancer...
Further Positive Interim Results From Aphton's Phase II Clinical Trial With Stomach Cancer Patients Presented At ASCO
- 2002-05-17
Business Editors/Health & Medical Writers American Society of Oncology ORLANDO, Fla.--BUSINESS WIRE--May 17, 2002 Aphton Corporation (Nasdaq:APHT) - At the annual meeting of the American Society of Oncology ASCO being held in Orlando, Florida, investigators are presenting highlights from several clinical trials and studies with Aphton's anti-gastrin...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| William A. Hasler | Co-CEO |
| Dov Michaeli | Senior Vice President, Global Development & Medical Science & Chief Medical Officer |
| James F. Smith | CFO |
| Manfred Ruediger | COO & Executive Vice President |
| Philip C. Gevas | CFO |
| Susan Anne Watson | Senior Vice President & Chief Scientific Officer |
| Frederick Jacobs | Vice President & Director, Finance |
| Jeannette L. Whitmore | Vice President & Director, Investor & Media Relations & Corp Communications |
| Paul Broome | Vice President & Director, Medical, Global Clinical Trials & Regulatory Affairs |
| Peter Blackburn | Vice President, Program Development & Manufacturing |
| Richard Ascione | Vice President & Director, Molecular Medicine Laboratory |
| Theo de Roij | Vice President, Business & Prod Development |
| Theo Roij | Vice President, Business and Product Development |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| David H. Sachs | Board of Directors |
| Georges Hibon | Board of Directors |
| Nicholas J. Stathis | Board of Directors |
| Robert S. Basso | Board of Directors |
| Vincent D. Enright | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Co-CEO | Current |
| Solectron Corporation | Chairman | Current |
| Boardvantage, Inc. | Board of Directors | Current |
| Technical Olympic USA, Inc. | Board Director | Current |
| Harris Stratex Networks, Inc. | Board of Directors | Current |
| Aphton Corporation | Vice Chairman | Current |
| DMC Stratex Networks, Inc. | Board Director | Current |
| Ditech Networks Inc. | Board of Directors | Current |
| Vitalect, Inc. | Board of Directors | Current |
| Mission West Properties | Board of Directors | Current |
| The Investment Bank for Middle Market | Board of Directors | Current |
| Insidetrack, Inc. | Member, Board of Directors | Current |
| Vitalect, Inc. | Investor | Current |
| Genitope Corporation | Compensation Committee Member | Current |
| Ditech.com | Compensation Committee Member | Current |
| Pomona College | Trustee | Former |
| Pacific Stock Exchange | public governor | Former |
| KPMG International | Director | Former |
| Ditech Communications Corporation | Board of Directors | Former |
| Solectron Corporation | Board Director | Former |
| Harvard University | M.B.A. | Former |
| Harvard Business School | MBA | Former |
| Pomona College | B.A. | Former |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Senior Vice President, Global Development & Medical Science & Chief Medical Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | CFO | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | COO & Executive Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | CFO | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Senior Vice President & Chief Scientific Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Vice President & Director, Finance | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Vice President & Director, Investor & Media Relations & Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Vice President & Director, Medical, Global Clinical Trials & Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Vice President, Program Development & Manufacturing | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Vice President & Director, Molecular Medicine Laboratory | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Vice President, Business & Prod Development | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Vice President, Business and Product Development | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Aphton Corporation | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
